To include your compound in the COVID-19 Resource Center, submit it here.

TNFerade: GNVC started a Phase IIb trial comparing TNFerade in combination with 5-FU and radiation therapy to 5-FU and radiation therapy alone in 140 patients w

GenVec Inc. (GNVC), Gaithersburg, Md.
Product: TNFerade

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE